Walgreen, Rite Aid Slam Dismissal Bid in Opana Antitrust MDL
Attempts by Endo Pharmaceuticals Inc. and Impax Laboratories to dismiss proposed class actions claiming Endo paid about $112 million to delay a generic version of painkiller Opana ER ignore several post-Actavis...To view the full article, register now.
Already a subscriber? Click here to view full article